Back to top

Analyst Blog

We are reiterating our Neutral recommendation on the shares of UnitedHealth Group Inc. (UNH - Analyst Report), following second quarter earnings results, which included a 10.2% positive earnings surprise. Over the past four quarters, this Zacks Rank #3 (Hold) company delivered positive surprise with an average beat of 11.1%

Why Reiterate?

On Jul 18, 2013, UnitedHealth Group reported its second-quarter 2013 earnings of $1.40 per share, higher than the Zacks Consensus Estimate of 1.26 per share. Earnings were also up 7.4% on a year-over-year basis.

Results reflected a solid performance from its health benefits business along with strong growth from Optum segment.

Counting on the positives, UnitedHealth is one of the biggest and most diversified health insurers in the U.S. It holds a huge market share in the Medicare market, which is expected to boom in the coming years as millions of Americans enter retirement. The company has made a number of acquisitions (most significant of which is the purchase of XL Health Corp.) to further strengthen its position in the Medicare Advantage  market, resulting in long-term growth.

UnitedHealth  is also expanding its accountable care contracts and intends to reach $50 billion mark over the coming five years.

UnitedHealth’s health service business is an essential part of the company’s diversification strategy. Management is considering the expansion of the health service business to produce 30%–40% of operating income over the longer term.

UnitedHealth is also expanding its business internationally. Geographical diversification features prominently in the company’s plan of action to overcome restrictions imposed by the Health Care Reform back in the U.S.

On the tepid side, UnitedHealth is also witnessing increased operating costs due to high medical and operating cost pressures related to the Affordable Care Act.

Though the company had experienced low medical care over the past couple of years, management expects it to return to normalized medical utilization trends soon. This will wipe out the extra earnings benefit the company had been enjoying so far.

Other stocks

Other health insurers,  such as Aetna Inc. (AET - Analyst Report), CIGNA Corp. (CI - Analyst Report), WellCare Health Plans Inc. (WCG - Snapshot Report), all with a Zacks Rank #2 (Buy), are worth considering.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.00 +3.09%
SANCHEZ ENE… SN 34.18 +2.67%
THE PANTRY… PTRY 21.02 +2.09%
INTEL CP INTC 35.15 +1.88%
PIPER JAFFR… PJC 54.54 +1.70%